Colchicine for secondary prevention of vascular events: a meta-analysis of trials

Journal:
European Heart Journal
Published:
DOI:
10.1093/eurheartj/ehaf210
Affiliations:
32
Authors:
25
Institutions Authors Share
University Medical Center Utrecht (UMC Utrecht), Netherlands
3.500000
0.14
McMaster University, Canada
2.083333
0.08
Population Health Research Institute (PHRI), Canada
1.583333
0.06
Meander Medical Centre, Netherlands
1.500000
0.06
Dutch Network for Cardiovascular Research (WCN), Netherlands
1.333333
0.05
University of Ottawa Heart Institute, Canada
1.000000
0.04
Clinic Saint-Jean, Belgium
1.000000
0.04
Harry Perkins Institute of Medical Research (HPIMR), Australia
1.000000
0.04
Ss. Cyril and Methodius University in Skopje (UKIM), North Macedonia
1.000000
0.04
Monash University, Australia
1.000000
0.04
Lyon University Hospital (HCL), France
1.000000
0.04
AP-HP Pitié-Salpêtrière Hospital, France
1.000000
0.04
Otamendi Hospital, Argentina
1.000000
0.04
Beijing Tiantan Hospital, Capital Medical University, China
1.000000
0.04
Hamilton General Hospital, HHS, Canada
0.583333
0.02
Bichat-Claude Bernard Hospital, France
0.500000
0.02
The University of Sydney (USYD), Australia
0.500000
0.02
Royal Prince Alfred Hospital (RPAH), USYD, Australia
0.500000
0.02
Hospital Universitario Virgen de la Arrixaca, Spain
0.500000
0.02
Institute of Health Carlos III (ISCIII), Spain
0.500000
0.02
VA NY Harbor Health Care System, United States of America (USA)
0.500000
0.02
NYU Langone Health, United States of America (USA)
0.500000
0.02
Noordwest Hospital Group, Netherlands
0.333333
0.01
Radboud University Medical Centre (Radboudumc), RU, Netherlands
0.333333
0.01
Mater Misericordae University Hospital (MMUH), Ireland
0.333333
0.01
University College Dublin (UCD), Ireland
0.333333
0.01
Irish Critical Care Clinical Trials Network (ICC-CTN), Ireland
0.333333
0.01
Centre Hospitalier Universitaire de Sherbrooke (CHUS), Canada
0.250000
0.01